Two Distinct Career Paths Offer Clear Choices

Big Pharma: Big markets. Traditional science. Big future and lofty salaries. Biotech: Lots of competition for smaller markets. Cutting-edge science. Iffy future, but tempting stock options. Such are the widely held perceptions regarding the industry sectors that employ life science researchers. Those perceptions have become clichés, and like all great clichés, they're not altogether accurate--but they do contain a kernel of truth. The real truth is, the maturing biotech industr

Written byJames Kling
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Big Pharma: Big markets. Traditional science. Big future and lofty salaries.

Biotech: Lots of competition for smaller markets. Cutting-edge science. Iffy future, but tempting stock options.

Such are the widely held perceptions regarding the industry sectors that employ life science researchers. Those perceptions have become clichés, and like all great clichés, they're not altogether accurate--but they do contain a kernel of truth.

The real truth is, the maturing biotech industry and the pharmaceutical giants are evolving organisms, and clichés that grew from the truisms of an emerging biotech industry in the 1980s need to be re-evaluated for the 1990s. For the job seeker searching for the right fit, it's time to put aside preconceived notions and take a hard look at the industries as they exist today. Whether you're a newly minted graduate, or a veteran seeking a change in scenery, there are a number of questions to ask and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies